You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Progression meningioma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Meningioma, Meningioma Atypical, Anaplastic Meningioma Trial in Rome (Biological biomarker assessment)

Recruiting
  • Meningioma
  • +2 more
  • Biological biomarker assessment
  • Rome, Italy
    Fondazione Policlinico Universitario A. Gemelli IRCCS
Mar 29, 2023

Meningioma Trial in Vandœuvre-lès-Nancy (Everolimus)

Not yet recruiting
  • Meningioma
  • Vandœuvre-lès-Nancy, Grand Est, France
  • +1 more
Nov 8, 2023

Role of the Tumor Microenvironment in Aggressive Meningiomas

Not yet recruiting
  • Meningioma
  • Surgical waste and Data collect
  • (no location specified)
Apr 7, 2023

Meningioma Trial in Heidelberg (Explorative biomarker study)

Not yet recruiting
  • Meningioma
  • Explorative biomarker study
  • Heidelberg, Germany
    University Hospital of Heidelberg, Radiation Oncology
Oct 23, 2023

Meningioma, Refractory Meningioma, Relapsed Meningioma Trial in Omaha (ONC201)

Not yet recruiting
  • Meningioma
  • +2 more
  • Omaha, Nebraska
    University of Nebraska Medical Center
Aug 21, 2023

Meningioma Trial in Miami (Cabozantinib)

Recruiting
  • Meningioma
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc
Jun 17, 2022

Meningioma, Meningioma, Adult Trial in Saint Louis (drug, radiation, procedure)

Active, not recruiting
  • Meningioma
  • Meningioma, Adult
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 27, 2022

Meningioma Trial in Phoenix (Abemaciclib, Placebo)

Not yet recruiting
  • Meningioma
  • Phoenix, Arizona
    St. Joseph's Hospital and Medical Center
Jul 4, 2023

Grade 1 Meningioma, Grade 2 Meningioma, Grade 3 Meningioma Trial in Rochester (radiation, drug, procedure, other)

Recruiting
  • Grade 1 Meningioma
  • +4 more
  • Gallium Ga 68-DOTATATE
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 11, 2023

Brain and CNS Tumors Trial in Canada, United States (54 Gy radiotherapy, 60 Gy radiotherapy)

Active, not recruiting
Has Results
  • Brain and Central Nervous System Tumors
  • 54 Gy radiotherapy
  • 60 Gy radiotherapy
  • Phoenix, Arizona
  • +77 more
Dec 15, 2022

Meningioma Atypical, Radiotherapy, Progression-Free Survival Trial (radiotherapy)

Not yet recruiting
  • Meningioma Atypical
  • +3 more
  • radiotherapy
  • (no location specified)
Oct 15, 2019

Brain Cancer Trial in United States (Optune (NovoTTF-100A))

Active, not recruiting
  • Brain Cancer
  • Optune (NovoTTF-100A)
  • Los Angeles, California
  • +8 more
Jul 1, 2022

Meningioma Trial (Radiotherapy 68 Gy(RBE), Radiotherapy 72 Gy(RBE), Radiotherapy 60 Gy(RBE))

Not yet recruiting
  • Meningioma
  • Radiotherapy 68 Gy(RBE)
  • +2 more
  • (no location specified)
Aug 2, 2022

Residual, Progressive or Recurrent Grade II or III Meningioma Trial (NEO100)

Not yet recruiting
  • Residual, Progressive or Recurrent Grade II or III Meningioma
  • (no location specified)
Aug 25, 2021

Meningioma Trial in Heidelberg (Carbon Ion Radiotherapy)

Active, not recruiting
  • Meningioma
  • Carbon Ion Radiotherapy
  • Heidelberg, Germany
    University Hopsital Heidelberg
Aug 23, 2022

Craniopharyngioma, Obesity Trial in Oldenburg

Recruiting
  • Craniopharyngioma
  • Obesity
    • Oldenburg, Niedersachsen, Germany
      Klinikum Oldenburg
    Mar 29, 2022

    Oncological Care for Patients With Meningioma

    Recruiting
    • Atypical Meningioma
    • +5 more
      • Montpellier, France
        Uh Montpellier
      Apr 13, 2022

      Meningiomas Trial in Boston (Nivolumab - 240 mg, Ipilimumab - 1 mg/kg, Nivolumab - 480 mg)

      Recruiting
      • Meningiomas
      • Nivolumab - 240 mg
      • +4 more
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Jan 3, 2022

      Liquid Biopsy in High-grade Gliomas and Meningiomas

      Recruiting
      • High Grade Glioma
      • High Grade Meningioma
        • Milano, MI, Italy
        • +4 more
        Nov 29, 2022

        Intracranial Meningioma Trial in United States (Everolimus, Bevacizumab)

        Terminated
        Has Results
        • Intracranial Meningioma
        • Orlando, Florida
        • +6 more
        Nov 8, 2021

        Meningioma, Malignant Trial in Beijing (Sintilimab)

        Recruiting
        • Meningioma, Malignant
        • Beijing, Beijing, China
          Beijing TianTan Hospital
        Aug 9, 2021

        High Grade Meningioma Trial in Boston (Pembrolizumab)

        Active, not recruiting
        • High Grade Meningioma
        • Boston, Massachusetts
        • +1 more
        Jul 29, 2021

        Glioblastoma Multiforme, Meningioma Trial in Phoenix (Ribociclib)

        Recruiting
        • Glioblastoma Multiforme
        • Meningioma
        • Phoenix, Arizona
          Barrow Brain and Spine
        Oct 7, 2021

        Grade II Meningioma, Intracranial Meningioma Trial in Worldwide (Clinical Observation, Radiation Therapy)

        Recruiting
        • Grade II Meningioma
        • Intracranial Meningioma
        • Clinical Observation
        • Radiation Therapy
        • Birmingham, Alabama
        • +184 more
        Jan 13, 2022

        Intracranial Meningioma, Recurrent Meningioma, NF2 Gene Mutation Trial in United States (Vismodegib, FAK Inhibitor GSK2256098,

        Recruiting
        • Intracranial Meningioma
        • +2 more
        • Birmingham, Alabama
        • +707 more
        Sep 25, 2022